Biolase Share Holder Equity 2010-2024 | BIOL

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Biolase share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Biolase share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items

Related Stocks
Company Name	Market Cap
Becton Dickinson (BDX)	$66.8B
McKesson (MCK)	$66.6B
Cardinal Health (CAH)	$26.9B
Cooper (COO)	$21.9B
West Pharmaceutical Services (WST)	$21.5B
Labcorp (LH)	$19.1B
Align Technology (ALGN)	$18.9B
Henry Schein (HSIC)	$9B
Merit Medical Systems (MMSI)	$5.7B
DENTSPLY SIRONA (XRAY)	$5.4B
CONMED (CNMD)	$2.3B
Patterson (PDCO)	$1.9B
STAAR Surgical (STAA)	$1.6B
Lifevantage (LFVN)	$125M
Pro-Dex (PDEX)	$83M